CTD HOLDINGS INC
10QSB, EX-27, 2000-11-14
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Previous: CTD HOLDINGS INC, 10QSB, 2000-11-14
Next: FOTOBALL USA INC, 10QSB, 2000-11-14



<TABLE> <S> <C>

<ARTICLE>                 5
<LEGEND>

     This  schedule  contains  summary  financial   information  extracted  from
Financial Statements for the 9 months ended September 30, 2000, and is qualified
in its entirety by reference to such form 10QSB for three months ended September
30, 2000.
</LEGEND>
<MULTIPLIER>                                                         1

<S>                                                       <C>
<PERIOD-TYPE>                                                    3-MOS
<FISCAL-YEAR-END>                                          DEC-31-2000
<PERIOD-START>                                             JUL-01-2000
<PERIOD-END>                                               SEP-30-2000
<CASH>                                                               0
<SECURITIES>                                                         0
<RECEIVABLES>                                                   54,044
<ALLOWANCES>                                                         0
<INVENTORY>                                                     60,576
<CURRENT-ASSETS>                                               170,743
<PP&E>                                                         534,019
<DEPRECIATION>                                                  97,991
<TOTAL-ASSETS>                                                 812,943
<CURRENT-LIABILITIES>                                          252,796
<BONDS>                                                              0
<COMMON>                                                     1,883,903
                                                0
                                                          0
<OTHER-SE>                                                           0
<TOTAL-LIABILITY-AND-EQUITY>                                   812,943
<SALES>                                                        313,130
<TOTAL-REVENUES>                                               313,248
<CGS>                                                           94,556
<TOTAL-COSTS>                                                  502,117
<OTHER-EXPENSES>                                                     0
<LOSS-PROVISION>                                                     0
<INTEREST-EXPENSE>                                              14,633
<INCOME-PRETAX>                                                      0
<INCOME-TAX>                                                         0
<INCOME-CONTINUING>                                           (203,502)
<DISCONTINUED>                                                       0
<EXTRAORDINARY>                                                      0
<CHANGES>                                                            0
<NET-INCOME>                                                  (207,502)
<EPS-BASIC>                                                       (.01)
<EPS-DILUTED>                                                        0


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission